Genmab — Marts 2019
-
ATP utilfreds med bonusfest i Genmab
Hård kritik af Genmabs bonuspolitik på generalforsamlingen.
Finans (finans.dk)
-
God morgen. Tak til Solsen.

-
Genmab-topchef får de ansattes skarpe spørgsmål frem med »cocktailtrick«
Genmabs topchef, Jan van de Winkel, er tilhænger af et ledelsesprincip, hvor han er i så tæt kontakt med sine ansatte som muligt. Biotek-bossen afslører her et lidt alternativt trick til at få lokket medarbejdere til at stille ham de svære spørgsmål.
Berlingske (www.berlingske.dk)
-
Enig gentogen
-
Synes de får bonus på forkant
-
Eller Aab.

-
Det var jo det de skrev under 6d https://ir.genmab.com/news-releases/news-release-details/genmab-summons-annual-general-meeting-14 De må købe 775000? aktier endnu indtil 2024. Men de skal vel bruges til RSU (Restricted Stock Units) uddeling ?
-
God morgen.

-
Tisotumab vedotin induces anti-tumor activity through MMAE-mediated, Fc-mediated, and Fab-mediated effector functions in vitro https://www.abstractsonline.com/pp8/#!/6812/presentation/2937
-
DR5 agonist activity of HexaBody
-DR5/DR5 (GEN1029) is potentiated by C1q and independent of Fc-gamma receptor binding in preclinical tumor models https://www.abstractsonline.com/pp8/#!/6812/presentation/2482
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind